يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"García Donas, J."', وقت الاستعلام: 1.24s تنقيح النتائج
  1. 1
    مؤتمر
  2. 2
    مؤتمر
  3. 3
  4. 4
    مؤتمر

    المساهمون: Ottawa Hospital Research Institute, Ottawa, Canada

    العلاقة: https://dx.doi.org/10.1136/ijgc-2020-IGCS.3Test; Weberpals J, Oza A, Lorusso D, Scambia G, Aghajanian C, Oaknin A, et al. Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations. International Journal of Gynecological Cancer. 2020;30:A2-A3.; http://hdl.handle.net/10541/623861Test; International Journal of Gynecological Cancer

  5. 5
    مؤتمر

    المساهمون: The Ohio State University, James Cancer Hospital, Columbus, OH, USA

    العلاقة: https://dx.doi.org/10.1016Test/j.ygyno.2020.06.153; O'Malley DM, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Postprogression outcomes in patients with ovarian carcinoma associated with a mutation in a non-BRCA homologous recombination repair gene receiving rucaparib maintenance treatment: Results from the phase III study ARIEL3. Gynecologic Oncology. 2020;159:74-5.; http://hdl.handle.net/10541/623506Test; Gynecologic Oncology

  6. 6
  7. 7
  8. 8
    مؤتمر

    المساهمون: Department of Surgery and Cancer, Imperial College London, London

    العلاقة: https://dx.doi.org/10.1093/annonc/mdz250.039Test; McNeish IA, Moreno V, Jayson G, Roxburgh P, Ginesta MPB, Garcia-Donas J, et al. 1031P OCTAVE: A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer. Annals of Oncology. 2019;30(Supplement_5):421.; http://hdl.handle.net/10541/622589Test; Annals of Oncology

  9. 9
  10. 10